In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [F-18]GE-180 and effect of docosahexaenoic acid

Centre for Trauma Sciences, funded by the Barts & The London Charity, GE Healthcare Ltd, the Experimental Medicine Awards from the Blizard Institute and the Imaging Centre at the Barts Cancer Institute

Mesenchymal Stem Cell Graft Improves Recovery after Spinal Cord Injury in Adult Rats through Neurotrophic and Pro-Angiogenic Actions

Numerous strategies have been managed to improve functional recovery after spinal cord injury (SCI) but an optimal strategy doesn't exist yet. Actually, it is the complexity of the injured spinal cord pathophysiology that begets the multifactorial approaches assessed to favour tissue protection, axonal regrowth and functional recovery. In this context, it appears that mesenchymal stem cells (MSCs) could take an interesting part. The aim of this study is to graft MSCs after a spinal cord compression injury in adult rat to assess their effect on functional recovery and to highlight their mechanisms of action. We found that in intravenously grafted animals, MSCs induce, as early as 1 week after the graft, an improvement of their open field and grid navigation scores compared to control animals. At the histological analysis of their dissected spinal cord, no MSCs were found within the host despite their BrdU labelling performed before the graft, whatever the delay observed: 7, 14 or 21 days. However, a cytokine array performed on spinal cord extracts 3 days after MSC graft reveals a significant increase of NGF expression in the injured tissue. Also, a significant tissue sparing effect of MSC graft was observed. Finally, we also show that MSCs promote vascularisation, as the density of blood vessels within the lesioned area was higher in grafted rats. In conclusion, we bring here some new evidences that MSCs most likely act throughout their secretions and not via their own integration/differentiation within the host tissue

Temperature and calcium ions affect aggregation of mesenchymal stem cells in phosphate buffered saline

Bone marrow-derived mesenchymal stem cells (MSC) are being extensively studied as potential therapeutic agents for various diseases and have demonstrated tremendous promise to date. To reduce immunological and inflammatory reaction upon delivery of MSC in situ, the cells are often suspended in protein-free and nutrient-poor buffered saline solution at high titers and kept on ice (0 °C) until completion of the transplantation procedure. This study investigated the effects of suspending MSC (5 × 106 cells/mL) in phosphate buffered saline (PBS) with and without calcium, over a time course of 90 and 180 min, at temperatures of 0 and 37 °C. The results at 0 °C showed a small but significant decrease in cell viability within calcium-free PBS after 180 min, whereas no significant changes in cell viability were observed with PBS containing calcium. Additionally, it was observed that significant aggregation of MSC into cellular clumps occurred when incubated in PBS at 0 °C, with a higher degree of aggregation occurring under calcium-free conditions. By contrast at 37 °C, there was a more pronounced decrease in cell viability after 90 and 180 min, but lesser aggregation of MSC both in the presence and absence of calcium. The aggregation of MSC into cellular clumps could pose an embolic hazard if delivered into the arterial vasculature in cardiac applications, can clog-up injection or infusion catheters utilized for cell delivery during surgery, and can also possibly reduce the overall efficacy of transplantation therapy

Neurosurgical untethering with or without syrinx drainage results in high patient satisfaction and favorable clinical outcome in post-traumatic myelopathy patients

Study design: Retrospective data collection and patient-reported outcome measures. Objectives: To investigate surgical outcome, complications, and patient satisfaction in patients with chronic SCI and symptomatic post-traumatic progressive myelopathy (PPM) who underwent neurosurgical untethering and/or spinal cord cyst drainage with the aim of preventing further neurological deterioration. Setting: Single-center study at an academic neurosurgery department. Methods: All SCI patients who underwent neurosurgery between 1996 and 2013 were retrospectively included. All medical charts and the treating surgeon’s operative reports were reviewed to identify surgical indications, surgical technique, and post-operative complications. A questionnaire and an EQ-5D-instrument were used to assess patient's self-described health status and satisfaction at long-term follow-up. Results: Fifty-two patients (43 men, 9 women) were identified, of whom five were dead and one was lost to follow-up. Main indications for surgery were pain (54%), motor (37%), or sensory (8%) impairment, and spasticity (2.0%). Overall complications were rare (8%). At follow-up, the subjectively perceived outcome was improved in 24 and remained unchanged in 21 patients. Thus, the surgical aim was met in 87% of patients. Of the 46 eligible patients, 38 responded to the questionnaire of whom 65% were satisfied with the surgical results. Patients with cervical lesions were more satisfied with the surgical treatment than patients with thoracic/thoracolumbar lesions (p = 0.05). Conclusions: Neurosurgical untethering and/or cyst drainage in chronic SCI patients and PPM resulted in a high degree of patient satisfaction, particularly in cervical SCI patients with minimal complications